tryptophan has been researched along with paclitaxel in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cangiano, C; Cascino, A; Fanfarillo, F; Fava, A; Muscaritoli, M; Peverini, P; Rossi Fanelli, F; Russo, M | 1 |
| Banerjee, T; DuHadaway, J; Hou, DY; Johnson, M; Mellor, AL; Muller, AJ; Munn, DH; Prendergast, GC; Sharma, MD | 1 |
| Akimoto, H; Inaba, T; Ino, K; Kajiyama, H; Kikkawa, F; Nagasaka, T; Nawa, A; Shibata, K; Takikawa, O; Yamamoto, E | 1 |
| Nelson, BH | 1 |
| Amano, S; Enomoto, K; Sakurai, K | 1 |
| Chen, X; Hou, Y; Li, C; Li, H; Li, K; Lou, G; Ning, X; Sun, F; Yin, M; Zhang, T; Zheng, J; Zhou, X | 1 |
| Le, V; Lin, S; Liu, J; Que, Z; Tian, J; Zhang, A; Zhang, L; Zheng, Y | 1 |
| da Cunha Bianchi, PK; Gebrim, LH; Kfoury, JR; Salvadori, ML; Silva, RS | 1 |
| Ash, A; Caruso, D; Corona, G; Crivellari, D; Giordano, A; Lombardi, D; Miolo, G; Muraro, E; Rizzolio, F; Scalone, S | 1 |
| Du, G; Liu, Q; Meng, X; Sun, S; Tian, J; Wang, H; Wang, W; Wu, Z; Ye, L | 1 |
| Calleja, P; Espuelas, S; Irache, JM; MartÃnez-Oharriz, C; Zandueta, C | 1 |
| Gao, S; Hu, Z; Lu, W; Xu, J; Zheng, B | 1 |
15 other study(ies) available for tryptophan and paclitaxel
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of cisplatin and paclitaxel on plasma free tryptophan levels. An in vitro study.
Topics: Cisplatin; Humans; In Vitro Techniques; Paclitaxel; Plasma; Reference Values; Serum Albumin; Tryptophan | 1999 |
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Drug Synergism; Female; HeLa Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Paclitaxel; Stereoisomerism; Tryptophan | 2007 |
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Drug Synergism; Female; Humans; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Transfection; Tryptophan; Xenograft Model Antitumor Assays | 2009 |
IDO and outcomes in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Drug Synergism; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocytes, Tumor-Infiltrating; Ovarian Neoplasms; Paclitaxel; Prognosis; Tryptophan | 2009 |
[Indoleamine 2,3-dioxygenase activity during chemotherapy or hormone therapy in patients with breast cancer].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chromatography, High Pressure Liquid; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Letrozole; Middle Aged; Nitriles; Paclitaxel; Triazoles; Tryptophan | 2010 |
A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Chromatography, Liquid; Female; Humans; Mass Spectrometry; Metabolomics; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Tryptophan; Uterine Cervical Neoplasms; Valine | 2014 |
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Disease Progression; Drug Screening Assays, Antitumor; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Saponins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Triterpenes; Tryptophan; Tumor Burden; Tumor Escape | 2014 |
Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Paclitaxel; Tryptophan; Tumor Cells, Cultured | 2015 |
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Least-Squares Analysis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pharmacogenetics; Receptor, ErbB-2; ROC Curve; Spermidine; Tandem Mass Spectrometry; Trastuzumab; Treatment Outcome; Tryptophan; Young Adult | 2016 |
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Imidazoles; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Interleukin-2; Isoindoles; Kynurenine; Male; Melanoma, Experimental; Mice, Inbred C57BL; Paclitaxel; T-Lymphocytes; Tryptophan; Tumor Burden | 2017 |
A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Solubility; Tryptophan; X-Ray Diffraction | 2017 |
An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
Topics: Albumins; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Compounding; Drug Synergism; Female; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; T-Lymphocytes, Regulatory; Treatment Outcome; Tryptophan; Xenograft Model Antitumor Assays | 2020 |